Understanding Petros Pharmaceuticals Inc (PTPI)’s financial health through ratios

In other words, the price has increased by $0.0000 from its previous closing price. On the day, 624855 shares were traded. PTPI stock price reached its highest trading level at $1.5501 during the session, while it also had its lowest trading level at $1.4400.

Ratios:

For a better understanding of PTPI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.71 and its Current Ratio is at 3.02. In the meantime, Its Debt-to-Equity ratio is 1.23 whereas as Long-Term Debt/Eq ratio is at 1.05.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTPI now has a Market Capitalization of 3.28M and an Enterprise Value of -6.00M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.47 while its Price-to-Book (P/B) ratio in mrq is 0.46. Its current Enterprise Value per Revenue stands at -0.86 whereas that against EBITDA is 0.69.

Stock Price History:

Over the past 52 weeks, PTPI has reached a high of $9.54, while it has fallen to a 52-week low of $0.92. The 50-Day Moving Average of the stock is 1.4029, while the 200-Day Moving Average is calculated to be 1.9000.

Shares Statistics:

Over the past 3-months, PTPI traded about 1.05M shares per day on average, while over the past 10 days, PTPI traded about 1.11M shares per day. A total of 2.08M shares are outstanding, with a floating share count of 1.31M. Insiders hold about 40.34% of the company’s shares, while institutions hold 5.30% stake in the company. Shares short for PTPI as of Feb 29, 2024 were 317.19k with a Short Ratio of 0.30, compared to 242.4k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 14.41% and a Short% of Float of 23.07%.

Earnings Estimates

Current recommendations for the stock of the company come from 1 analysts. The consensus estimate for the next quarter is -$1.19, with high estimates of -$1.19 and low estimates of -$1.19.

Analysts are recommending an EPS of between -$5.15 and -$5.15 for the fiscal current year, implying an average EPS of -$5.15. EPS for the following year is -$5.01, with 1 analysts recommending between -$5.01 and -$5.01.

Revenue Estimates

Based on 1 analysts’ estimates, the company’s revenue will be $6M in the next fiscal year. The high estimate is $6M and the low estimate is $6M. The average revenue growth estimate for next year is down -22.10% from the average revenue estimate for this year.

Most Popular

[the_ad id="945"]